EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, SC Ropharma's enterprise value is lei211.4 Mil.
SC Ropharma's Revenue for the trailing twelve months (TTM) ended in Jun. 2023 was lei503.0 Mil. Therefore, SC Ropharma's EV-to-Revenue for today is 0.42.
The historical rank and industry rank for SC Ropharma's EV-to-Revenue or its related term are showing as below:
BSE:RPH'
s EV-to-Revenue Range Over the Past 10 Years
Min: 0.23 Med: 0.38 Max: 0.57
Current: 0.42
During the past 13 years, the highest EV-to-Revenue of SC Ropharma was 0.57. The lowest was 0.23. And the median was 0.38.
BSE:RPH's EV-to-Revenue is ranked better than 87.48% of 663
companies
in the Healthcare Providers & Services industry
Industry Median: 1.89
vs BSE:RPH: 0.42
As of today (2024-05-08), SC Ropharma's stock price is lei0.19.
SC Ropharma's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 was lei0.98. Therefore, SC Ropharma's PS Ratio for today is 0.19.
SC Ropharma EV-to-Revenue Historical Data
The historical data trend for SC Ropharma's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of SC Ropharma's EV-to-Revenue
For the Pharmaceutical Retailers subindustry, SC Ropharma's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SC Ropharma's EV-to-Revenue Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, SC Ropharma's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where SC Ropharma's EV-to-Revenue falls into.
SC Ropharma's current Enterprise Value is lei211.4 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. SC Ropharma's Revenue for the trailing twelve months (TTM) ended in Jun. 2023 was lei503.0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SC Ropharma's share price for today is lei0.19.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Jun. 2023 was lei0.98.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SC Ropharma EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of SC Ropharma's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
SC Ropharma SA is engaged in the production, distribution, and Retail sale of pharmaceutical products in specialized stores. Its product portfolio comprises over 50 products in the form of tablets, powders, capsules, and syrups covering 21 therapeutic areas.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BSE:RPH has been successfully added to your 